Market Place
Sourcing Support
Nabriva hit with 2nd FDA complete response letter for Contepo
23 Jun 2020 //
FIERCE PHARMA
Nabriva Receives Complete Response Letter from FDA on NDA for (fosfomycin)
21 Jun 2020 //
BIOSPACE
Recommendations to restrict use of fosfomycin antibiotics
27 Mar 2020 //
EMA
Add Interquim Project: PCS7 updating project in a regulated Pharma environment
02 Mar 2020 //
PRESS RELEASE
Nabriva Therapeutics Receives FDA Acknowledgement of NDA Resubmission
08 Jan 2020 //
GLOBE NEWSWIRE
Nabriva Therapeutics Receives FDA Acknowledgement of NDA Resubmission
07 Jan 2020 //
GLOBE NEWSWIRE
Nabriva Therapeutics Receives FDA Acknowledgement of NDA Resubmission
07 Jan 2020 //
GLOBE NEWSWIRE
Nabriva Therapeutics Resubmits NDA for Intravenous fosfomycin for Injection
20 Dec 2019 //
GLOBENEWS WIRE
Meeting highlights from the CHMP 10-13 December 2018
14 Dec 2018 //
Nabriva snaps up Zavante for its market-ready antibiotic
02 Aug 2018 //
PHARMA TECH
Bristol-Myers Squibb, Tsinghua University pen drug discovery pact
24 Jul 2018 //
FIERCE BIOTECH
Zavante Closes $45Mn Series A Financing In Support Of Injectable Antibiotic
31 Mar 2016 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.